Cargando…
Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021
BACKGROUND: Utilising national surveillance data, we investigated the impact of the COVID-19 immunisation campaign on COVID-19 morbidity and mortality between December/2020 and October/2021 in Germany. METHODS: We compared patterns in immunisation coverage, incidence, hospitalisations, and deaths am...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990687/ https://www.ncbi.nlm.nih.gov/pubmed/35428498 http://dx.doi.org/10.1016/j.vaccine.2022.04.002 |
_version_ | 1784683429097373696 |
---|---|
author | Perumal, Nita Steffen, Annika Ullrich, Alexander Siedler, Anette |
author_facet | Perumal, Nita Steffen, Annika Ullrich, Alexander Siedler, Anette |
author_sort | Perumal, Nita |
collection | PubMed |
description | BACKGROUND: Utilising national surveillance data, we investigated the impact of the COVID-19 immunisation campaign on COVID-19 morbidity and mortality between December/2020 and October/2021 in Germany. METHODS: We compared patterns in immunisation coverage, incidence, hospitalisations, and deaths among 12–17, 18–59, and 60+ year-olds and examined these patterns within the context of anti-pandemic measures. RESULTS: COVID-19 incidence increased in all age groups following the end of lockdown restrictions in March/2021, but as Germany experienced successive peaks in incidence, age groups with higher immunisation coverage experienced successively smaller peaks. Notwithstanding corresponding increases during periods of higher incidence, among those aged 60+ years, COVID-19 related hospitalisations and deaths declined considerably as immunisation coverage increased, despite circulation of virus variants known to cause more severe illness. CONCLUSION: Although ecological in nature, this study allows us to demonstrate clear patterns of decline in COVID-19 morbidity and mortality in Germany during the course of the immunisation campaign. |
format | Online Article Text |
id | pubmed-8990687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89906872022-04-11 Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 Perumal, Nita Steffen, Annika Ullrich, Alexander Siedler, Anette Vaccine Short Communication BACKGROUND: Utilising national surveillance data, we investigated the impact of the COVID-19 immunisation campaign on COVID-19 morbidity and mortality between December/2020 and October/2021 in Germany. METHODS: We compared patterns in immunisation coverage, incidence, hospitalisations, and deaths among 12–17, 18–59, and 60+ year-olds and examined these patterns within the context of anti-pandemic measures. RESULTS: COVID-19 incidence increased in all age groups following the end of lockdown restrictions in March/2021, but as Germany experienced successive peaks in incidence, age groups with higher immunisation coverage experienced successively smaller peaks. Notwithstanding corresponding increases during periods of higher incidence, among those aged 60+ years, COVID-19 related hospitalisations and deaths declined considerably as immunisation coverage increased, despite circulation of virus variants known to cause more severe illness. CONCLUSION: Although ecological in nature, this study allows us to demonstrate clear patterns of decline in COVID-19 morbidity and mortality in Germany during the course of the immunisation campaign. Elsevier Ltd. 2022-05-09 2022-04-08 /pmc/articles/PMC8990687/ /pubmed/35428498 http://dx.doi.org/10.1016/j.vaccine.2022.04.002 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Perumal, Nita Steffen, Annika Ullrich, Alexander Siedler, Anette Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
title | Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
title_full | Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
title_fullStr | Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
title_full_unstemmed | Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
title_short | Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
title_sort | impact of covid-19 immunisation on covid-19 incidence, hospitalisations, and deaths by age group in germany from december 2020 to october 2021 |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990687/ https://www.ncbi.nlm.nih.gov/pubmed/35428498 http://dx.doi.org/10.1016/j.vaccine.2022.04.002 |
work_keys_str_mv | AT perumalnita impactofcovid19immunisationoncovid19incidencehospitalisationsanddeathsbyagegroupingermanyfromdecember2020tooctober2021 AT steffenannika impactofcovid19immunisationoncovid19incidencehospitalisationsanddeathsbyagegroupingermanyfromdecember2020tooctober2021 AT ullrichalexander impactofcovid19immunisationoncovid19incidencehospitalisationsanddeathsbyagegroupingermanyfromdecember2020tooctober2021 AT siedleranette impactofcovid19immunisationoncovid19incidencehospitalisationsanddeathsbyagegroupingermanyfromdecember2020tooctober2021 |